Clearstead Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Clearstead Trust’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.9K	Sell	497 -1,134	-70%	-$36.1K	﹤0.01%	451
2026 Q1	$43.1K	Sell	1,631 -4,681	-74%	-$137K	0.01%	331
2025 Q4	$183K	Hold	6,312	–	–	0.03%	202
2025 Q3	$175K	Hold	6,312	–	–	0.03%	192
2025 Q2	$154K	Hold	6,312	–	–	0.03%	197
2025 Q1	$131K	Hold	6,312	–	–	0.03%	186
2024 Q4	$149K	Sell	6,312 -2,032	-24%	-$50K	0.03%	174
2024 Q3	$214K	Hold	8,344	–	–	0.05%	131
2024 Q2	$196K	Hold	8,344	–	–	0.05%	130
2024 Q1	$240K	Hold	8,344	–	–	0.06%	124
2023 Q4	$274K	Buy	8,344 +3,157	+61%	+$85.8K	0.07%	137
2023 Q3	$145K	Buy	5,187 +1,500	+41%	+$49K	0.05%	153
2023 Q2	$126K	Sell	3,687 -32	-0.9%	-$1.01K	0.04%	163
2023 Q1	$112K	Hold	3,719	–	–	0.04%	175
2022 Q4	$105K	Sell	3,719 -2,303	-38%	-$73.1K	0.04%	179
2022 Q3	$198K	Buy	+6,022	New	+$221K	0.07%	123
2022 Q1	–	Sell	-69	Closed	-$4K	–	192
2021 Q4	$4K	Hold	69	–	–	﹤0.01%	177
2021 Q3	$5K	Hold	69	–	–	﹤0.01%	180
2021 Q2	$6K	Buy	+69	New	+$5.87K	﹤0.01%	153

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Clearstead Trust's ARKG Position: Q2 2026 in Review

Clearstead Trust reduced its ARK Genomic Revolution ETF (ARKG) stake by 70% in Q2 2026, selling an estimated $36.1K and leaving 497 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #451.

Clearstead Trust first reported a position in ARKG in Q2 2021 and has held it in 19 quarters since. The position peaked at $274K in Q4 2023. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Clearstead Trust held 497 shares of ARK Genomic Revolution ETF worth $20.9K as of Q2 2026.
Clearstead Trust sold 1,134 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $36.1K.
ARK Genomic Revolution ETF made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #451 holding.
Clearstead Trust first reported a position in ARK Genomic Revolution ETF in Q2 2021 and has held it in 19 quarters since.
Clearstead Trust's ARK Genomic Revolution ETF position peaked at $274K in Q4 2023.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.